Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-invasive Neuromodulation to Enhance Targeted Cognitive Remediation in Older Adults With Depression

NCT05400512 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT05400512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05400512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-invasive Neuromodulation to Enhance Targeted Cognitive Remediation in Older Adults With Depression
Lead sponsor
Vanderbilt University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
February 8, 2023
Completion date
August 18, 2025
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging, cognitive symptom, depression